157 related articles for article (PubMed ID: 26856813)
1. Participation and health care provision of statutory skin cancer screening in Germany - a secondary data analysis.
Anastasiadou Z; Schäfer I; Siebert J; Günther W; Reusch M; Augustin M
J Eur Acad Dermatol Venereol; 2016 Mar; 30(3):424-7. PubMed ID: 26856813
[TBL] [Abstract][Full Text] [Related]
2. Skin Cancer Screening in Germany. Documenting Melanoma Incidence and Mortality From 2008 to 2013.
Katalinic A; Eisemann N; Waldmann A
Dtsch Arztebl Int; 2015 Sep; 112(38):629-34. PubMed ID: 26429634
[TBL] [Abstract][Full Text] [Related]
3. Systematic skin cancer screening in Northern Germany.
Breitbart EW; Waldmann A; Nolte S; Capellaro M; Greinert R; Volkmer B; Katalinic A
J Am Acad Dermatol; 2012 Feb; 66(2):201-11. PubMed ID: 22074699
[TBL] [Abstract][Full Text] [Related]
4. Does skin cancer screening save lives? A detailed analysis of mortality time trends in Schleswig-Holstein and Germany.
Stang A; Jöckel KH
Cancer; 2016 Feb; 122(3):432-7. PubMed ID: 26480048
[TBL] [Abstract][Full Text] [Related]
5. Skin cancer screening participation and impact on melanoma incidence in Germany--an observational study on incidence trends in regions with and without population-based screening.
Waldmann A; Nolte S; Weinstock MA; Breitbart EW; Eisemann N; Geller AC; Greinert R; Volkmer B; Katalinic A
Br J Cancer; 2012 Feb; 106(5):970-4. PubMed ID: 22294187
[TBL] [Abstract][Full Text] [Related]
6. [Regional differences in the health care of basal cell carcinoma].
Augustin J; Schäfer I; Thiess P; Reusch M; Augustin M
Hautarzt; 2016 Oct; 67(10):822-828. PubMed ID: 27465368
[TBL] [Abstract][Full Text] [Related]
7. Effects of the German skin cancer screening programme on melanoma incidence and indicators of disease severity.
Trautmann F; Meier F; Seidler A; Schmitt J
Br J Dermatol; 2016 Nov; 175(5):912-919. PubMed ID: 27203791
[TBL] [Abstract][Full Text] [Related]
8. Routine skin cancer screening in Germany: four years of experience from the dermatologists' perspective.
Kornek T; Schäfer I; Reusch M; Blome C; Herberger K; Beikert FC; Augustin M
Dermatology; 2012; 225(4):289-93. PubMed ID: 23295723
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of skin cancer screening in Germany - participation, tumor detection and interval tumors based on SHI data.
Garbe C; Augustin M; Augustin J; Baltus H; Eisemann N; Hübner J; Katalinic A; Wolf S; Hagenström K
J Dtsch Dermatol Ges; 2023 Dec; 21 Suppl 5():3-11. PubMed ID: 38063281
[TBL] [Abstract][Full Text] [Related]
10. Frequency of excisions and yields of malignant skin tumors in a population-based screening intervention of 360,288 whole-body examinations.
Waldmann A; Nolte S; Geller AC; Katalinic A; Weinstock MA; Volkmer B; Greinert R; Breitbart EW
Arch Dermatol; 2012 Aug; 148(8):903-10. PubMed ID: 22911184
[TBL] [Abstract][Full Text] [Related]
11. Skin cancer rates in North Rhine-Westphalia, Germany before and after the introduction of the nationwide skin cancer screening program (2000-2015).
Stang A; Jöckel KH; Heidinger O
Eur J Epidemiol; 2018 Mar; 33(3):303-312. PubMed ID: 29294207
[TBL] [Abstract][Full Text] [Related]
12. [Incidence of melanoma and changes in stage-specific incidence after implementation of skin cancer screening in Schleswig-Holstein].
Eisemann N; Waldmann A; Katalinic A
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Jan; 57(1):77-83. PubMed ID: 24357176
[TBL] [Abstract][Full Text] [Related]
13. Cervical cancer screening in Germany: group-specific participation rates in the state of Niedersachsen (Lower Saxony). A study with health insurance data.
Geyer S; Jaunzeme J; Hillemanns P
Arch Gynecol Obstet; 2015 Mar; 291(3):623-9. PubMed ID: 25138124
[TBL] [Abstract][Full Text] [Related]
14. Melanoma mortality following skin cancer screening in Germany.
Boniol M; Autier P; Gandini S
BMJ Open; 2015 Sep; 5(9):e008158. PubMed ID: 26373399
[TBL] [Abstract][Full Text] [Related]
15. Does skin cancer screening save lives?: an observational study comparing trends in melanoma mortality in regions with and without screening.
Katalinic A; Waldmann A; Weinstock MA; Geller AC; Eisemann N; Greinert R; Volkmer B; Breitbart E
Cancer; 2012 Nov; 118(21):5395-402. PubMed ID: 22517033
[TBL] [Abstract][Full Text] [Related]
16. The German SCREEN project--design and evaluation of the communication strategy.
Anders MP; Nolte S; Waldmann A; Capellaro M; Volkmer B; Greinert R; Breitbart EW
Eur J Public Health; 2015 Feb; 25(1):150-5. PubMed ID: 24760725
[TBL] [Abstract][Full Text] [Related]
17. Regional variations in the use of statutory skin cancer screenings in Germany: population-based spatial multisource analysis.
Augustin J; Sorbe C; Augustin M; Zander N; Kis A
J Eur Acad Dermatol Venereol; 2020 Aug; 34(8):1736-1743. PubMed ID: 31981431
[TBL] [Abstract][Full Text] [Related]
18. The many unanswered questions related to the German skin cancer screening programme.
Stang A; Garbe C; Autier P; Jöckel KH
Eur J Cancer; 2016 Sep; 64():83-8. PubMed ID: 27371911
[TBL] [Abstract][Full Text] [Related]
19. Development of a microsimulation of melanoma mortality for evaluating the effectiveness of population-based skin cancer screening.
Eisemann N; Waldmann A; Garbe C; Katalinic A
Med Decis Making; 2015 Feb; 35(2):243-54. PubMed ID: 25145574
[TBL] [Abstract][Full Text] [Related]
20. Which factors influence the participation in statutory skin cancer screenings in Germany?
Andrees V; Wolf S; Liebers J; Augustin M; Girbig G
J Dtsch Dermatol Ges; 2024 Jun; 22(6):775-781. PubMed ID: 38656802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
